| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c84239a2b0af80249bfd25af57f45450
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac6bc8f0189e8b9086c4747a99ec201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251dbe11c5b1f7b3ab6d6787fe7c57dd |
| publicationDate |
2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-537995-A |
| titleOfInvention |
Inclusion complex of aripiprazole in a substituted b-cyclodextrin |
| abstract |
Disclosed is an inclusion complex of aripiprazole in a substituted b-cyclodextrin, wherein the b-cyclodextrin is sulfobutyl ether b-cyclodextrin(SBECD) or hydroxypropyl b-cyclodextrin (HPBCD). Also disclosed is a pharmaceutical formulation comprising aripiprazole and a substituted b-cyclodextrin, wherein the substituted b-cyclodextrin is sulfobutyl ether b-cyclodextrin (SBECD) or hydroxypropyl b-cyclodextrin (HPBCD). Aqueous injectable formulations comprising aripiprazole and the above substituted b-cyclodextrins are suitable for administering to a patient without causing unacceptable irritation at the site of injection. |
| priorityDate |
2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |